Minerva Neurosciences, Inc. Income (Loss) from Continuing Operations, Per Diluted Share
Minerva Neurosciences, Inc. (NERV) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.17 per share for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2021-03-08
- Minerva Neurosciences, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2020-12-31 was -$0.17.
- Minerva Neurosciences, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2020-09-30 was -$0.19.
- Minerva Neurosciences, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2020-06-30 was $0.73.
- Minerva Neurosciences, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2020-03-31 was -$0.31.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month |
|---|---|
| 2020-12-31 | -$0.17 10-K · filed 2021-03-08 |
| 2020-09-30 | -$0.19 10-K · filed 2021-03-08 |
| 2020-06-30 | $0.73 10-K · filed 2021-03-08 |
| 2020-03-31 | -$0.31 10-K · filed 2021-03-08 |
| 2019-12-31 | -$0.77 10-K · filed 2021-03-08 |
| 2019-09-30 | -$0.36 10-K · filed 2021-03-08 |
| 2019-06-30 | -$0.32 10-K · filed 2021-03-08 |
| 2019-03-31 | -$0.41 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |